CAN DYSPLASIA SURVEILLANCE BE BETTER TARGETED BY USING FAECAL CALPROTECTIN MEASUREMENTS IN ULCERATIVE COLITIS?

Anna-Maija Puolanne  1     Sami Qadri  2     Tiina Vesterinen  2     Saara Hiltunen  3     Aaro Mustonen  3     Johanna Arola  3     Kaija-Leena Kolho  3     Martti A. Färkkilä  3    
1 Helsinki University Hospital, Helsinki, Finland
2 Minerva Foundation Institute for Medical Research, Helsinki, Finland
3 BCB Medical Ltd., Espoo, Finland

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing